Navigation Links
Lutonix Inc. Announces $20 Million Series B Financing
Date:10/27/2008

Versant Ventures Leads Investment in Lutonix to Fund Human Clinical Trials

MINNEAPOLIS, Oct. 27 /PRNewswire/ -- Lutonix Inc., today announced the close of a $20 million Series B financing. Co-Founded in July 2007 by Dennis Wahr, M.D. and Lixiao Wang PhD, Lutonix is a medical device company focused on the development and commercialization of drug coated balloon angioplasty technology for the treatment and prevention of coronary and peripheral artery stenosis caused by atherosclerosis. Lutonix's drug coated balloon technology is anticipated to enhance therapeutic options for patients who are candidates for conventional therapies such as balloon angioplasty and stents and for those who are no longer likely to benefit from those treatments. Lutonix's first targeted indication is expected to be the treatment and prevention of vascular restenosis through the use of its proprietary, drug coated balloon angioplasty catheter. Lutonix will use the new capital for continued product development activities and to fund the company's initial human clinical trials.

The round was led by Versant Ventures (http://www.versantventures.com), a leading healthcare-focused venture capital firm, that was joined by new investor, Delphi Ventures (http://www.Delphiventures.com). Also participating in this round were both Series A investors, U.S. Venture Partners (http://www.usvp.com) and founding venture firm RiverVest Venture Partners (http://www.rivervest.com). In conjunction with the financing, Kevin Wasserstein, Managing Director of Versant Ventures, and John Maroney, Managing Director of Delphi Ventures have been added to the Board of Directors, which also includes: Jonathan Root, M.D., Managing Director of U.S. Venture Partners; Jay Schmelter, Managing Dire
'/>"/>

SOURCE Lutonix Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014  Formex, ... manufacturing, announced that Mr. Greg Weilersbacher joined Formex ... 25, 2014. Greg Weilersbacher ... experience with focused expertise in Quality Assurance, ... Mr. Weilersbacher brings to Formex a ...
(Date:9/16/2014)... , Sept. 16, 2014 On September 25 ... exhibition focusing on medical design and manufacturing - MEDTEC ... Shanghai World Expo Exhibition & Convention Center, bringing together ... and regions to showcase their latest medical-grade raw materials, ... only one week remaining for free visitor pre-registration to ...
(Date:9/16/2014)... , Sept. 16, 2014 CorMedix ... focused on developing and commercializing therapeutic products for ... infectious diseases, announces the amendment and restatement of ... preferred stock and related warrants, as well as ... stock and warrant financing, to remove anti-dilution, price ...
Breaking Medicine Technology:Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3
... Mylan Inc. (Nasdaq: MYL ) today announced ... from the U.S. Food and Drug Administration (FDA) for ... Levodopa Tablets USP, 10mg/100mg, 25mg/100mg and 25mg/250 mg. , ... Bristol Myers Squibb,s Parkinson,s treatment Sinemet®, 10mg/100mg, 25mg/100mg and ...
... JERUSALEM, Israel, September 30 Gamida Cell ... generic,name of what is widely known as "StemEx", as ... The article, carlecortemcel-l, an ex vivo expanded,umbilical cord blood ... Chan and Dr. Demetrios Petropoulos, will be published in ...
Cached Medicine Technology:Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma 3
(Date:9/16/2014)... who received hypofractionated (HPFX) radiation therapy (RT) reported ... bladder and bowel function were at similar levels ... today at the American Society for Radiation Oncology,s ... parallel quality of life outcomes occurred between groups ... RT. , The phase I/II trial enrolled 343 ...
(Date:9/16/2014)... (parous women) appear to have an increased risk ... that carries a higher mortality rate and is ... A similar relationship was found for triple-negative breast ... risk of estrogen receptor-negative and triple-negative breast cancer ... never breastfed. These findings, published in the ...
(Date:9/16/2014)... of getting prostate cancer after a worldwide team of ... genetic biomarkers, reported in Nature Genetics today. ... Jyotsna Batra and Distinguished Professor Judith Clements, who led ... hubs around the world, said the teams analysed more ... "It,s the largest analysis of genetic biomarkers ever done. ...
(Date:9/16/2014)... 16, 2014 Definitive Healthcare ... and healthcare providers, is pleased to announce the ... online database, now available for subscription, features detailed ... health system affiliations. , The Canadian database spans ... intelligence on over 750 hospitals. Each hospital ...
(Date:9/16/2014)... 16, 2014 Gary F. Locke, the ... has selected Worldwide Speakers Group for exclusive representation of ... of Commerce and Governor of Washington, Locke is widely ... U.S.-China relations, global expansion, and business growth. , “Gary ... and how to grow an organization’s global presence in ...
Breaking Medicine News(10 mins):Health News:Prostate cancer patients who receive hypofractionated RT report consistent QoL 2Health News:Prostate cancer patients who receive hypofractionated RT report consistent QoL 3Health News:Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk 2Health News:New gene research helps pinpoint prostate cancer risk 2Health News:Canadian Hospital Database Now Offered by Definitive Healthcare 2Health News:Gary Locke, Former Ambassador to China, Selects Worldwide Speakers Group for Exclusive Lecture Representation 2
... by day. The number of infections a person has been ... death from heart attack. It is long been suspected that ... This has been possible by promoting inflammation within the coronary ... have conflicting evidence. ,According to researchers at University ...
... (Dietary Approaches to Stop Hypertension) says by reducing salt ... effective in decreasing blood pressure as antihypertensive medications.In addition, ... decrease in the prevalence of heart disease and a ... ,The DASH-Sodium study included 342 people. More than half ...
... to a new study the use of serotonin-raising drugs ... a stroke. In common the mecahnism of durgs is ... with many different roles in the body.// Examples include ... antidepressants. ,Researchers at the Health welfare hospital, ...
... of the American Chemical Society indicated that cooking vegetables ... our body can absorb from them.// Tung-Ching Lee, a food ... vegetables and found that 25 of them benefited from cooking ... iron content in the vegetable is the same before and ...
... amount of fruit and vegetables, but they are still only a ... a booster to our human system.On an average the percentage of ... increased from 15 per cent to18 per cent between 1993 and ... ,Among women, the percentage increase was from 20 per cent to ...
... impairment. A new hearing device that is implanted in the ... aid. Doctors say that there's now a better option for ... sound through the eardrum, and may produce feedback - distracting ... the feeling of talking within a barrel. ,The ...
Cached Medicine News:
... three-dimensional VCS technology, providing ... efficiency in white cell ... With its reputation for ... is an affordable solution ...
Creatinine Test Kit (enzymatic), Wavelength: 340 nm. Linear range: up to 20 mg/dL....
For the quantitative determination of Creatine Kinase in serum....
For the qualitative determination of magnesium in serum....
Medicine Products: